Sodium Alginate as a Potential Therapeutic Filler: An In Vivo Study in Rats

Filler injection demand is increasing worldwide, but no ideal filler with safety and longevity currently exists. Sodium alginate (SA) is the sodium salt of alginic acid, which is a polymeric polysaccharide obtained by linear polymerization of two types of uronic acid, <span style="font-varia...

Full description

Bibliographic Details
Main Authors: Masanori Mori, Rintaro Asahi, Yoshihiro Yamamoto, Takanobu Mashiko, Kayo Yoshizumi, Natsumi Saito, Takako Shirado, Yunyan Wu, Kotaro Yoshimura
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Marine Drugs
Subjects:
Online Access:https://www.mdpi.com/1660-3397/18/10/520
_version_ 1797550625847771136
author Masanori Mori
Rintaro Asahi
Yoshihiro Yamamoto
Takanobu Mashiko
Kayo Yoshizumi
Natsumi Saito
Takako Shirado
Yunyan Wu
Kotaro Yoshimura
author_facet Masanori Mori
Rintaro Asahi
Yoshihiro Yamamoto
Takanobu Mashiko
Kayo Yoshizumi
Natsumi Saito
Takako Shirado
Yunyan Wu
Kotaro Yoshimura
author_sort Masanori Mori
collection DOAJ
description Filler injection demand is increasing worldwide, but no ideal filler with safety and longevity currently exists. Sodium alginate (SA) is the sodium salt of alginic acid, which is a polymeric polysaccharide obtained by linear polymerization of two types of uronic acid, <span style="font-variant: small-caps;">d</span>-mannuronic acid (M) and <span style="font-variant: small-caps;">l</span>-guluronic acid (G). This study aimed to evaluate the therapeutic value of SA. Nine SA types with different M/G ratios and viscosities were tested and compared with a commercially available sodium hyaluronate (SH) filler. Three injection modes (onto the periosteum, intradermally, or subcutaneously) were used in six rats for each substance, and the animals were sacrificed at 4 or 24 weeks. Changes in the diameter and volume were measured macroscopically and by computed tomography, and histopathological evaluations were performed. SA with a low M/G ratio generally maintained skin uplift. The bulge gradually decreased over time but slightly increased at 4 weeks in some samples. No capsule formation was observed around SA. However, granulomatous reactions, including macrophage recruitment, were observed 4 weeks after SA implantation, although fewer macrophages and granulomatous reactions were observed at 24 weeks. The long-term volumizing effects and degree of granulomatous reactions differed depending on the M/G ratio and viscosity. By contrast, SH showed capsule formation but with minimal granulomatous reactions. The beneficial and adverse effects of SA as a filler differed according to the viscosity or M/G ratio, suggesting a better long-term volumizing effect than SH with relatively low immunogenicity
first_indexed 2024-03-10T15:31:58Z
format Article
id doaj.art-e4768dc1afbd43daa4234d41cc3a21df
institution Directory Open Access Journal
issn 1660-3397
language English
last_indexed 2024-03-10T15:31:58Z
publishDate 2020-10-01
publisher MDPI AG
record_format Article
series Marine Drugs
spelling doaj.art-e4768dc1afbd43daa4234d41cc3a21df2023-11-20T17:36:17ZengMDPI AGMarine Drugs1660-33972020-10-01181052010.3390/md18100520Sodium Alginate as a Potential Therapeutic Filler: An In Vivo Study in RatsMasanori Mori0Rintaro Asahi1Yoshihiro Yamamoto2Takanobu Mashiko3Kayo Yoshizumi4Natsumi Saito5Takako Shirado6Yunyan Wu7Kotaro Yoshimura8Department of Plastic Surgery, Jichi Medical University, Tochigi 329-0498, JapanDepartment of Plastic Surgery, Jichi Medical University, Tochigi 329-0498, JapanDepartment of Plastic Surgery, Jichi Medical University, Tochigi 329-0498, JapanDepartment of Plastic Surgery, Jichi Medical University, Tochigi 329-0498, JapanDepartment of Plastic Surgery, Jichi Medical University, Tochigi 329-0498, JapanDepartment of Plastic Surgery, Jichi Medical University, Tochigi 329-0498, JapanDepartment of Plastic Surgery, Jichi Medical University, Tochigi 329-0498, JapanDepartment of Plastic Surgery, Jichi Medical University, Tochigi 329-0498, JapanDepartment of Plastic Surgery, Jichi Medical University, Tochigi 329-0498, JapanFiller injection demand is increasing worldwide, but no ideal filler with safety and longevity currently exists. Sodium alginate (SA) is the sodium salt of alginic acid, which is a polymeric polysaccharide obtained by linear polymerization of two types of uronic acid, <span style="font-variant: small-caps;">d</span>-mannuronic acid (M) and <span style="font-variant: small-caps;">l</span>-guluronic acid (G). This study aimed to evaluate the therapeutic value of SA. Nine SA types with different M/G ratios and viscosities were tested and compared with a commercially available sodium hyaluronate (SH) filler. Three injection modes (onto the periosteum, intradermally, or subcutaneously) were used in six rats for each substance, and the animals were sacrificed at 4 or 24 weeks. Changes in the diameter and volume were measured macroscopically and by computed tomography, and histopathological evaluations were performed. SA with a low M/G ratio generally maintained skin uplift. The bulge gradually decreased over time but slightly increased at 4 weeks in some samples. No capsule formation was observed around SA. However, granulomatous reactions, including macrophage recruitment, were observed 4 weeks after SA implantation, although fewer macrophages and granulomatous reactions were observed at 24 weeks. The long-term volumizing effects and degree of granulomatous reactions differed depending on the M/G ratio and viscosity. By contrast, SH showed capsule formation but with minimal granulomatous reactions. The beneficial and adverse effects of SA as a filler differed according to the viscosity or M/G ratio, suggesting a better long-term volumizing effect than SH with relatively low immunogenicityhttps://www.mdpi.com/1660-3397/18/10/520fillersodium alginatealginic acidsodium hyaluronatehyaluronic acidgranuloma
spellingShingle Masanori Mori
Rintaro Asahi
Yoshihiro Yamamoto
Takanobu Mashiko
Kayo Yoshizumi
Natsumi Saito
Takako Shirado
Yunyan Wu
Kotaro Yoshimura
Sodium Alginate as a Potential Therapeutic Filler: An In Vivo Study in Rats
Marine Drugs
filler
sodium alginate
alginic acid
sodium hyaluronate
hyaluronic acid
granuloma
title Sodium Alginate as a Potential Therapeutic Filler: An In Vivo Study in Rats
title_full Sodium Alginate as a Potential Therapeutic Filler: An In Vivo Study in Rats
title_fullStr Sodium Alginate as a Potential Therapeutic Filler: An In Vivo Study in Rats
title_full_unstemmed Sodium Alginate as a Potential Therapeutic Filler: An In Vivo Study in Rats
title_short Sodium Alginate as a Potential Therapeutic Filler: An In Vivo Study in Rats
title_sort sodium alginate as a potential therapeutic filler an in vivo study in rats
topic filler
sodium alginate
alginic acid
sodium hyaluronate
hyaluronic acid
granuloma
url https://www.mdpi.com/1660-3397/18/10/520
work_keys_str_mv AT masanorimori sodiumalginateasapotentialtherapeuticfilleraninvivostudyinrats
AT rintaroasahi sodiumalginateasapotentialtherapeuticfilleraninvivostudyinrats
AT yoshihiroyamamoto sodiumalginateasapotentialtherapeuticfilleraninvivostudyinrats
AT takanobumashiko sodiumalginateasapotentialtherapeuticfilleraninvivostudyinrats
AT kayoyoshizumi sodiumalginateasapotentialtherapeuticfilleraninvivostudyinrats
AT natsumisaito sodiumalginateasapotentialtherapeuticfilleraninvivostudyinrats
AT takakoshirado sodiumalginateasapotentialtherapeuticfilleraninvivostudyinrats
AT yunyanwu sodiumalginateasapotentialtherapeuticfilleraninvivostudyinrats
AT kotaroyoshimura sodiumalginateasapotentialtherapeuticfilleraninvivostudyinrats